Drug Trial Radar · NCT03919071
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
58
Planned (sponsor's estimate)
Start
Feb 20, 2020
Primary completion
Sep 30, 2027
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Apr 18, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 3 years, up to 25 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial studies how well the combination of dabrafenib and trametinib works after radiation therapy in children and young adults with high grade glioma who have a genetic change called BRAF V600 mutation. Radiation therapy uses high energy rays to kill tumor cells and reduce the size of tumors. Dabrafenib and trametinib may stop the growth of tumor cells by blocking BRAF and MEK, respectively, which are enzymes that tumor cells need for their growth. Giving dabrafenib with trametinib after radiation therapy may work better than treatments used in the past in patients with newly-diagnosed BRAF V600-mutant high-grade glioma.
Conditions
- Anaplastic Astrocytoma
- Anaplastic Astrocytoma, Not Otherwise Specified
- Anaplastic Ganglioglioma
- Anaplastic Pleomorphic Xanthoastrocytoma
- Glioblastoma
- Malignant Glioma
- WHO Grade 3 Glioma
- WHO Grade 4 Glioma
Interventions
Biospecimen CollectionProcedure
Undergo collection of blood
Dabrafenib MesylateDrug
Given PO
Lumbar PunctureProcedure
Undergo lumbar puncture
Magnetic Resonance ImagingProcedure
Undergo MRI
Radiation TherapyRadiation
Undergo RT
Trametinib Dimethyl SulfoxideDrug
Given PO
Primary outcomes
What the sponsor says the trial is designed to measure.
- Event-free survival (EFS) for stratum 1Time frame: From the date of diagnosis until disease progression date, secondary malignant neoplasm occurrence date, death date of any cause, or last follow-up, assessed up to 5 years
Locations
131 sites in 2 countries. Site status is shown where the registry gives one.
Children's Hospital of Alabama
Birmingham, Alabama
Banner Children's at Desert
Mesa, Arizona
Phoenix Childrens Hospital
Phoenix, Arizona
Arkansas Children's Hospital
Little Rock, Arkansas
Kaiser Permanente Downey Medical Center
Downey, California
Loma Linda University Medical Center
Loma Linda, California
Miller Children's and Women's Hospital Long Beach
Long Beach, California
Children's Hospital Los Angeles
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
Kaiser Permanente-Oakland
Oakland, California
Children's Hospital of Orange County
Orange, California
Lucile Packard Children's Hospital Stanford University
Palo Alto, California
University of California Davis Comprehensive Cancer Center
Sacramento, California
UCSF Medical Center-Mission Bay
San Francisco, California
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California
Children's Hospital Colorado
Aurora, Colorado
Connecticut Children's Medical Center
Hartford, Connecticut
Yale University
New Haven, Connecticut
Alfred I duPont Hospital for Children
Wilmington, Delaware
MedStar Georgetown University Hospital
Washington D.C., District of Columbia
Children's National Medical Center
Washington D.C., District of Columbia
Golisano Children's Hospital of Southwest Florida
Fort Myers, Florida
UF Health Cancer Institute - Gainesville
Gainesville, Florida
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Hollywood, Florida
Nemours Children's Clinic-Jacksonville
Jacksonville, Florida
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida
Nicklaus Children's Hospital
Miami, Florida
AdventHealth Orlando
Orlando, Florida
Arnold Palmer Hospital for Children
Orlando, Florida
Nemours Children's Hospital
Orlando, Florida
Sacred Heart Hospital
Pensacola, Florida
Johns Hopkins All Children's Hospital
St. Petersburg, Florida
Tampa General Hospital
Tampa, Florida
Saint Joseph's Hospital/Children's Hospital-Tampa
Tampa, Florida
Saint Mary's Medical Center
West Palm Beach, Florida
Children's Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, Georgia
Memorial Health University Medical Center
Savannah, Georgia
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii
Saint Luke's Cancer Institute - Boise
Boise, Idaho
Lurie Children's Hospital-Chicago
Chicago, Illinois
Showing 40 of 131 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.